Skip to content

Structure Therapeutics Inc.

GPCR Nasdaq SEC CIK 1888886

Follow Structure Therapeutics Weekly email: filings, results, news

News

3 stories filed under Structure Therapeutics, grouped into ongoing threads

Programs

Thread · 2 stories

Structure Therapeutics Inc. (GPCR) Discusses Positive Clinical Data Updates for Oral Small Molecule Amylin and GLP-1 Programs in Chronic Weight Management Transcript

Markets 15 d ago also on GLP

Septerna: GPCR Programs May Be Experimental, But I'm Holding For The Long Term

Markets 27 d ago also on SEPN

More coverage

Structure Therapeutics: A Strong Bet For An Oral GLP-1 Approval Before 2030

Markets 34 d ago also on GLP

Profile

Headquarters: SOUTH SAN FRANCISCO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 3 stories clustered from the RSS aggregator